The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity

  • Cell Metab. 2012 Jun 6;15(6):838-47. doi: 10.1016/j.cmet.2012.04.022.
Carles Cantó  1 ,  Riekelt H Houtkooper ,  Eija Pirinen ,  Dou Y Youn ,  Maaike H Oosterveer ,  Yana Cen ,  Pablo J Fernandez-Marcos ,  Hiroyasu Yamamoto ,  Pénélope A Andreux ,  Philippe Cettour-Rose ,  Karl Gademann ,  Chris Rinsch ,  Kristina Schoonjans ,  Anthony A Sauve ,  Johan Auwerx
Affiliations
  • 1. École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
Abstract

As NAD(+) is a rate-limiting cosubstrate for the Sirtuin enzymes, its modulation is emerging as a valuable tool to regulate Sirtuin function and, consequently, oxidative metabolism. In line with this premise, decreased activity of PARP-1 or CD38-both NAD(+) consumers-increases NAD(+) bioavailability, resulting in SIRT1 activation and protection against Metabolic Disease. Here we evaluated whether similar effects could be achieved by increasing the supply of nicotinamide riboside (NR), a recently described natural NAD(+) precursor with the ability to increase NAD(+) levels, Sir2-dependent gene silencing, and replicative life span in yeast. We show that NR supplementation in mammalian cells and mouse tissues increases NAD(+) levels and activates SIRT1 and SIRT3, culminating in enhanced oxidative metabolism and protection against high-fat diet-induced metabolic abnormalities. Consequently, our results indicate that the natural vitamin NR could be used as a nutritional supplement to ameliorate metabolic and age-related disorders characterized by defective mitochondrial function.